Clinical Trials | June 03, 2026
Cancer drug “iza-bren” posts strong Phase 3 wins across multiple tumor types
The companies say the drug has now demonstrated clinical benefit in three separate Phase 3 trials
The companies say the drug has now demonstrated clinical benefit in three separate Phase 3 trials
This facility plays an important role in Granules’ global manufacturing and supply network
The safety profile was described as manageable, though not without notable toxicities
First immunotherapy combination approved in the US for BCG-naïve high-risk NMIBC demonstrates a 32% reduction in the risk of disease recurrence, progression, or death
An exploratory overall survival signal also leaned in favor of the combination, though the companies noted the result remains preliminary
The trial results are for the pharma powerhouse's RET-targeted therapy Retevmo (selpercatinib)
Collaboration brings Staart Prime, ChilRun and NikoMom products to Yoginii’s platform, strengthening its family-focused wellness ecosystem and supporting women through motherhood and family care
The therapy also delivered significant improvements in key liver enzyme markers
Derived from rice bran wax, Licocare RBW products offer a renewable solution with a substantially lower carbon footprint than conventional montan waxes
The results confirm the study’s primary endpoint of objective response rate and now deliver a striking signal in progression-free survival
Subscribe To Our Newsletter & Stay Updated
